Literature DB >> 21468691

Apoptosis signal-regulating kinase1 is inducible by protein kinase Cδ and contributes to phorbol ester-mediated G1 phase arrest through persistent JNK activation.

Young-Rae Kim1, Hee Sun Byun, Juhee Jeon, Byung Lyul Choi, Kyeong Ah Park, Minho Won, Tiejun Zhang, Sanghee Shin, Hyunji Lee, Junseo Oh, Gang Min Hur.   

Abstract

Although protein kinase Cδ (PKCδ) has been suggested in the negative control of the cell cycle machinery in many types of cancer cells, its underlying mechanisms are partly understood. Here we report that the expression of apoptosis signal-regulating kinase1 (ASK1) is inducible in a PKCδ-dependent manner, and contributes to phorbol ester-induced cell cycle arrest through persistent JNK activation in breast cancer epithelial cells. Activation of PKC with phorbol 12-myristate 13-acetate (PMA) gradually up-regulated the expression of ASK1 mRNA and protein, and subsequently enhanced its catalytic activity in MCF-7 cells. Importantly, such PMA-induced ASK1 expression was completely abolished by pretreatment of rottlerin, a specific PKCδ inhibitor or by knocking down the expression of PKCδ, while ectopic expression of a constitutively active form of PKCδ strongly up-regulated ASK1 expression. We also found that the persistent activation of mitogen-activated protein kinase, JNK in response to PMA was greatly attenuated by RNA interference-mediated knockdown of ASK1. Taken together, these results suggest that inducible expression of ASK1 by PKCδ contributes to the G1 arrest by enhancing persistent JNK signaling activation which represents a novel alternative mechanism of PKCδ-dependent cell cycle arrest and limiting proliferation of breast cancer epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468691     DOI: 10.1007/s12013-011-9189-1

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  2 in total

1.  ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Authors:  Kei Miyakawa; Satoko Matsunaga; Kazuhiko Kanou; Atsushi Matsuzawa; Ryo Morishita; Ayumi Kudoh; Keisuke Shindo; Masaru Yokoyama; Hironori Sato; Hirokazu Kimura; Tomohiko Tamura; Naoki Yamamoto; Hidenori Ichijo; Akifumi Takaori-Kondo; Akihide Ryo
Journal:  Nat Commun       Date:  2015-04-22       Impact factor: 14.919

2.  Preclinical Activity of Simvastatin Induces Cell Cycle Arrest in G1 via Blockade of Cyclin D-Cdk4 Expression in Non-Small Cell Lung Cancer (NSCLC).

Authors:  Yu-Wei Liang; Chi-Chang Chang; Chao-Ming Hung; Tzu-Yu Chen; Tzuu-Yuan Huang; Yi-Chiang Hsu
Journal:  Int J Mol Sci       Date:  2013-03-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.